FDA Inspection 654181 — Carter BloodCare - Irving

Carter BloodCare - Irving — FEI 3003103575

The FDA completed an inspection of Carter BloodCare - Irving on Mar 11, 2010 in Irving, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 11, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Irving, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.